Cohance Lifesciences Limited (BOM:543064)

India flag India · Delayed Price · Currency is INR
980.40
-17.10 (-1.71%)
At close: Aug 1, 2025
-1.71%
Market Cap356.97B
Revenue (ttm)11.98B
Net Income (ttm)2.68B
Shares Outn/a
EPS (ttm)10.45
PE Ratio133.26
Forward PE54.11
Dividendn/a
Ex-Dividend Daten/a
Volume6,187
Average Volume5,773
Open980.05
Previous Close997.50
Day's Range954.45 - 987.25
52-Week Range921.50 - 1,359.00
Betan/a
RSI31.90
Earnings DateAug 8, 2025

About Cohance Lifesciences

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company ... [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 1,193
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543064
Full Company Profile

Financial Performance

In 2024, Cohance Lifesciences's revenue was 11.98 billion, an increase of 13.91% compared to the previous year's 10.51 billion. Earnings were 2.68 billion, a decrease of -10.79%.

Financial Statements

News

There is no news available yet.